ASAP ASCENDIS SIGNATURE ACCESS PROGRAM

Serial Number 90557693
Registration 7342066
700

Registration Progress

Application Filed
Mar 3, 2021
Under Examination
Approved for Publication
Jan 16, 2024
Published for Opposition
Jan 16, 2024
Registered
Apr 2, 2024

Trademark Image

ASAP ASCENDIS SIGNATURE ACCESS PROGRAM

Basic Information

Serial Number
90557693
Registration Number
7342066
Filing Date
March 3, 2021
Registration Date
April 2, 2024
Published for Opposition
January 16, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 2, 2024
Registration
Registered
Classes
036 041 044

Rights Holder

Ascendis Pharma A/S

99
Address
Tuborg Boulevard 12
Hellerup 2900
DK

Ownership History

Ascendis Pharma A/S

Original Applicant
99
Hellerup DK

Ascendis Pharma A/S

Owner at Publication
99
Hellerup DK

Ascendis Pharma A/S

Original Registrant
99
Hellerup DK

Legal Representation

Attorney
Shannon Marie McKeon

USPTO Deadlines

Next Deadline
1611 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-02)
Due Date
April 02, 2030
Grace Period Ends
October 02, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Apr 2, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 2, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 6, 2024 CHPB I POST PUBLICATION AMENDMENT - ENTERED Loading...
Feb 6, 2024 ISPO Z WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST Loading...
Feb 5, 2024 APET A ASSIGNED TO PETITION STAFF Loading...
Jan 16, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 16, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 27, 2023 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Dec 12, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 12, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 12, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 12, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 12, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 14, 2023 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Sep 26, 2023 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Sep 11, 2023 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Sep 8, 2023 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Sep 6, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 8, 2023 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Apr 13, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Dec 19, 2022 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Nov 30, 2022 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Nov 29, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 23, 2022 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Apr 19, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Apr 19, 2022 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Apr 19, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
Mar 23, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 23, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 23, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 26, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 26, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 26, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 25, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 3, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jun 2, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 6, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 036
Patient support program, namely, advancement of funds for covering pharmaceutical and medical expenses and providing information about eligibility for financial assistance provided through patient benefits programs; pharmaceutical and pharmacy benefit management services, namely, provision of information for patients in relation to obtaining benefits relating to medical treatment and pharmaceuticals
Class 041
Educational services, namely, conducting educational programs for patients and healthcare providers in the field of growth hormone deficiency, endocrine disorders, and bone and skeletal disorders; educational services, namely, training patients and healthcare providers in the field of self-administering medications
Class 044
Patient support program, namely, providing health care information to patients and healthcare providers in the field of growth hormone deficiency, endocrine disorders, and bone and skeletal disorders diagnosis and treatment including providing information on self-administering medications; administering a quick start patient assistance program to provide patients with limited free supplies of drugs to initiate therapy while obtaining benefits or insurance coverage

Additional Information

Design Mark
The mark consists of the stylized wording "ASAP", with small diamonds between the letters, and the stylized wording "ASCENDIS SIGNATURE ACCESS PROGRAM" underneath.

Classification

International Classes
036 041 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ACCESS PROGRAM"